Moderna says its booster dose proved effective against Omicron in lab study
Moderna said early Monday that a third dose of its COVID-19 vaccine significantly increased immune responses against the Omicron coronavirus variant in lab tests, adding more preliminary evidence that booster shots restore protections eroded by the new variant.
Moderna said in a press release that the half-dose it has been using as a booster increases neutralizing antibody levels 37-fold versus pre-booster levels. Neutralizing antibodies, The Wall Street Journal explains, "are among the first soldiers that the immune system deploys to battle invaders like the coronavirus." Pfizer reported earlier that its third dose boosted neutralizing antibodies against Omicron more than 25-fold.
"What we showed is when you boost, you get a good brisk increase in antibody levels and they would be correlated with protection," Moderna Chief Medical Officer Paul Burton told the Journal. Using a full 100-microgram does for the booster pumped up neutralizing antibody levels 83-fold, and Burton said regulators should consider using full doses for people at higher risk of more severe COVID-19. Moderna decided on a half dose for the third shot to reduce adverse effects, usually fevers, fatigue, and muscle aches.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Dr. Eric Topol, founder and director of the Scripps Research Translational Institute, said a half dose should prove sufficient, if Moderna's lab research is borne out in the real world. "I think it's pretty encouraging," he told USA Today. "We'll take any positive we can get."
Omicron has shown itself to evade previous infections and inoculations, though even two doses of the Pfizer and Moderna vaccine (and one dose of the Johnson & Johnson shot plus a Pfizer or Moderna booster) are effective at preventing serious illness and hospitalization. The hope is that a booster shot will also prevent infection and curb the spread of the highly transmissible variant.
Moderna said it is also testing an Omicron-specific vaccine, but given the time needed to roll out a new vaccine, it is focusing its efforts on producing more of its original formula so people can get boosted.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
The World of Tim Burton: a 'creepy, witty and visually ravishing' exhibition
The Week Recommends Sprawling show at the Design Museum features over 600 exhibits from across the directors' five-decade career from early sketches to costumes and props
By Irenie Forshaw, The Week UK Published
-
Crossword: October 31, 2024
The Week's daily crossword
By The Week Staff Published
-
Sudoku hard: October 31, 2024
The Week's daily hard sudoku puzzle
By The Week Staff Published
-
McDonald's sued over E. coli linked to burger
Speed Read The outbreak has sickened at least 49 people in 10 states and left one dead
By Rafi Schwartz, The Week US Published
-
Israel, UN agree to Gaza pauses for polio vaccinations
Speed Read Gaza's first case of polio in 25 years was confirmed last week in a 10-month-old boy who is now partially paralyzed
By Rafi Schwartz, The Week US Published
-
WHO declares mpox a global health emergency
Speed Read An outbreak of the viral disease formerly known as monkeypox continues to spread in Africa
By Rafi Schwartz, The Week US Published
-
Have we defeated malaria?
The Explainer Roll-out of low-cost vaccine means a world free from disease that claims 600,000 lives a year 'finally within sight'
By The Week UK Published
-
Roll-out of affordable malaria vaccine begins
Speed Read R21 is approved for babies and may save hundreds of thousands of lives
By Arion McNicoll, The Week UK Published
-
Texas dairy worker gets bird flu from infected cow
Speed Read The virus has been spreading among cattle in Texas, Kansas, Michigan and New Mexico
By Peter Weber, The Week US Published
-
Dengue hits the Americas hard and early
Speed Read Puerto Rico has declared an epidemic as dengue cases surge
By Peter Weber, The Week US Published
-
US bans final type of asbestos
Speed Read Exposure to asbestos causes about 40,000 deaths in the U.S. each year
By Peter Weber, The Week US Published